Lane Labs AdvaCAL TV Ads Breaking In Mid-January
This article was originally published in The Tan Sheet
Executive Summary
Lane Labs is supporting the introduction of AdvaCAL calcium supplements to drug stores with a $7 mil. television and print advertising campaign.
You may also be interested in...
AdvaCal
Calcium in Lane Labs' supplement, which combines oyster shell with an algal ingredient, is better absorbed than calcium carbonate, Takuo Fujita, et al., Calcium Research Institute, Osaka and National Sanatorium Hyogo Chuo Hospital, Japan, report in a poster presentation. AdvaCal appears to be effective in increasing BMD in osteoporosis and osteopenia alone and in conjunction with drugs, the Japanese researchers say. Lane Labs has cited Fujita's work in its promotions for AdvaCal (1"The Tan Sheet" Nov. 8, 1999, p. 16)
NCI Phase III Trial On Shark Cartilage May Begin Recruitment Summer/Fall
A National Cancer Institute Phase III trial on the effects of shark cartilage on stages 3a and 3b inoperable non-small cell lung cancer may begin recruitment in the late summer or early fall.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC